Healthcare -
Biotechnology - NASDAQ - US
$ 1.53
-0.649 %
$ 4.88 M
Market Cap
-0.13
P/E
MBRX - COST OF REVENUE
Cost of Revenue MBRX - Moleculin Biotech, Inc.
127 K
LAST VALUE
-30.11%
2 YEAR CAGR
13.31%
5 YEAR CAGR
0.00%
10 YEAR CAGR